JIN Financial Statements From 2010 to 2025
| ZJYL Stock | 0.89 0.04 4.71% |
Check JIN MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JIN MEDICAL's main balance sheet or income statement drivers, such as , as well as many indicators such as . JIN financial statements analysis is a perfect complement when working with JIN MEDICAL Valuation or Volatility modules.
JIN |
JIN MEDICAL INTERNATIONAL Company Shares Outstanding Analysis
JIN MEDICAL's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current JIN MEDICAL Shares Outstanding | 156.55 M |
Most of JIN MEDICAL's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JIN MEDICAL INTERNATIONAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, JIN MEDICAL INTERNATIONAL has 156.55 M of shares currently outstending. This is 13.29% lower than that of the Health Care Equipment & Supplies sector and 10.52% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 72.62% higher than that of the company.
JIN MEDICAL INTERNATIONAL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining JIN MEDICAL's current stock value. Our valuation model uses many indicators to compare JIN MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across JIN MEDICAL competition to find correlations between indicators driving JIN MEDICAL's intrinsic value. More Info.JIN MEDICAL INTERNATIONAL is rated second in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for JIN MEDICAL INTERNATIONAL is roughly 2.25 . Comparative valuation analysis is a catch-all technique that is used if you cannot value JIN MEDICAL by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About JIN MEDICAL Financial Statements
JIN MEDICAL investors utilize fundamental indicators, such as revenue or net income, to predict how JIN Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of JIN MEDICAL Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.